Clinical trials are enrolling patients in Spain and Switzerland for NovaGo Therapeutics AG, which is backed by investors including Pureos and Neurimmune.
2 reports, 1 independent
Updated Sep 2
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Clinical trials are enrolling patients in Spain and Switzerland for NovaGo Therapeutics AG, which is backed by investors including Pureos and Neurimmune.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Spain
country in southwestern Europe with territories in Africa
-
Switzerland
country in Central Europe